| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT04058964 Details | 2020-03-13 Interventional | 2 | 0 | Pembrolizumab Pancreatic Neop… Metastatic Panc… Stage IV Pancre… | Study withdrawn by supporter - | |||
| NCT03580694 Details | 2020-03-13 Interventional | 1 | 17 | Cemiplimab Carcinoma, Non-… Lung Neoplasms | Program reprioritization - | |||
| NCT02819999 Details | 2020-03-12 Interventional | 1 | 28 | Etoposide Rovalpituzumab … Lung Neoplasms Small Cell Lung… Small Cell Lung… | Strategic considerations - | |||
| NCT02756728 Details | 2020-03-12 Interventional | 1/2 | 5 | Melphalan Multiple Myelom… Neoplasms, Plas… | Full clinical hold from FDA - | |||
| NCT03529929 Details | 2020-03-11 Interventional | 3 | 0 | Methylprednisol… Methylprednisol… Methylprednisol… Prednisolone Prednisolone ac… Prednisolone he… Prednisolone ph… Inflammation Aging | withdrawn - | |||
| NCT01094262 2009-016831-36 Details | 2020-03-11 Interventional | 2 | 196 | Analgesics Oxycodone Arthralgia Osteoarthritis Osteoarthritis,… Joint Pain Pain | Logistic reasons associated with the FDA-imposed clinical hold. - | |||
| NCT02401542 2017-001319-36 Details | 2020-03-09 Interventional | 1/2 | 71 | Docetaxel Carcinoma Urinary Bladder… Urologic Diseas… Locally Advance… Urinary Bladder… Urological Dise… | program has been put on hold by the sponsor - | |||
| NCT03290196 Details | 2020-03-06 Interventional | 4 | - | Bupivacaine Pain, Postopera… Rotator Cuff In… Rotator Cuff Te… | Patients pain was not regulated well with this product. - | |||
| NCT03678090 Details | 2020-03-05 Interventional | 2 | 0 | Plasminogen Tissue Plasmino… Lung Neoplasms Pleural Effusio… Pleural Effusio… Cancer, Lung | Local IRB recommended IND exemption from FDA, study timeline not able to be met. - | |||
| NCT02875093 Details | 2020-03-05 Interventional | 1 | 23 | Cytarabine Leukemia Leukemia, Myelo… Leukemia, Myelo… Acute Myeloid L… | Study Termination - | |||
| NCT03862079 Details | 2020-03-04 Interventional | 2 | 0 | Nystatin Piperacillin Piperacillin, T… Tazobactam Graft vs Host D… Graft-versus-ho… | Per PI's request - | |||
| NCT02739360 2015-005766-39 Details | 2020-03-04 Interventional | 4 | 3 | Idelalisib Neoplasms Lymphoid Malign… | - - | |||
| NCT01742793 Details | 2020-03-04 Interventional | 1 | 12 | Lenalidomide Romidepsin Hodgkin Disease Lymphoma Lymphoma, T-Cel… Lymphoma, T-Cel… Multiple Myelom… Neoplasms, Plas… Hodgkin's Lymph… Mature T-cell L… | The study was terminated due to withdrawal of institutional support, Phase II never began. - | |||
| NCT04020653 Details | 2020-03-03 Interventional | 2 | 0 | Aminolevulinic … Artemether Artemisinin Artemisinins Citric Acid Ferrous citrate Lumefantrine Sodium Citrate Malaria | Considering the Thai FDA requirement, changes of Malaria cases in Thailand and EC
recommendation, the decision to withdrawal the study was made. - | |||
| NCT02784483 Details | 2020-03-03 Interventional | 1 | 2 | Atezolizumab Multiple Myelom… Neoplasms, Plas… Smoldering Mult… Asymptomatic My… | Based on FDA requirements - | |||
| NCT01863719 Details | 2020-03-02 Interventional | 1 | 27 | Colistin Pneumococcal In… Pneumonia Pathogen Resist… Pneumococcal In… | Completion of cohort 3, safety concerns - | |||
| NCT00512044 Details | 2020-03-02 Interventional | 4 | 0 | Anesthetics Hemorrhoids | slow recruitment, internal problems with the study protocol - | |||
| NCT03278808 Details | 2020-02-27 Interventional | 2 | [4 Refs] | 0 | Atovaquone Atovaquone, pro… Azithromycin Chloroquine Chloroquine dip… Proguanil Malaria | The IND has been withdrawn from FDA - | ||
| NCT03019120 Details | 2020-02-26 Interventional | 2 | 0 | Vitamin D Cognitive Dysfu… Vitamin D Defic… Neurocognitive … | Due to administrative reasons, it was not possible to enroll subjects. - | |||
| NCT03498222 Details | 2020-02-25 Interventional | 1 | 0 | Atezolizumab Carboplatin Pemetrexed Carcinoma, Non-… | Funder and IMP manufacturer withdrew support - |